Showing results (91-100 of 105) with videos related to
Sort By:
Pageof 11
Vaccine|September 30, 2010
Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriageDlawer A A Ala'aldeen, Mike Flint, Neil J Oldfield, et al.Allergy|May 4, 2016
Can we identify patients at risk of life-threatening allergic reactions to food?P J Turner, J L Baumert, K Beyer, et al.Archives of Disease in Childhood|July 20, 2022
Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021Helen Ratcliffe, K S Tiley, Nick Andrews, et al.Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.The Journal of Infection|June 18, 2023
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trialEimear Kelly, Melanie Greenland, Philip C S de Whalley, et al.The Journal of Infection|December 3, 2025
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trialE Kelly, M Greenland, P de Whalley, et al.Lancet (London, England)|August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialXinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.Iscience|December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsHelen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programmeJeremy P Carr, Jenny M MacLennan, Emma Plested, et al.The Lancet. Respiratory Medicine|June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trialRobert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.Pageof 11